Lenoss Medical & Torigen Pharmaceuticals

At its next meeting on December 8, 2020, Beacon Angels will entertain the new company presentations from the following:

  • Lenoss Medical, which offers a natural, biological implant solution for spinal fractures to be supplemented with new bone and for the fracture to naturally heal while eliminating all the associated risk of the current standard of care of injecting a synthetic epoxy cement; and
  • Torigen Pharmaceuticals, which is developing affordable anti-cancer biologics for dogs and cats.

Members will report on companies in due diligence consisting of: 

  • Ocular Technologies, and
  • Amplify

We shall hear updates on the new funding rounds of:

  • Cognoptix convertible debt; and
  • RevBio (f/k/a Launchpad Medical).

Beacon Angels members will deliver portfolio company updates.

About Angel Treaty

Dedicated to fostering due diligence sharing between angel groups.
This entry was posted in Uncategorized and tagged , , . Bookmark the permalink.